Compile Data Set for Download or QSAR
Report error Found 97 Enz. Inhib. hit(s) with Target = 'LanC-like protein 2'
TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661328(US20240101552, Compound L-88)
Affinity DataKd:  1.64E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661339(US20240101552, Compound L-101)
Affinity DataKd:  2.33E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661338(US20240101552, Compound L-100)
Affinity DataKd:  3.85E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661337(US20240101552, Compound L-99)
Affinity DataKd:  5.41E+3nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661336(US20240101552, Compound L-98)
Affinity DataKd:  1.22E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661335(US20240101552, Compound L-96)
Affinity DataKd:  1.91E+3nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661334(US20240101552, Compound L-95)
Affinity DataKd:  2.09E+3nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661333(US20240101552, Compound L-93)
Affinity DataKd:  5.84E+3nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661332(US20240101552, Compound L-92)
Affinity DataKd:  5.88E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661331(US20240101552, Compound L-91)
Affinity DataKd:  1.71E+3nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661330(US20240101552, Compound L-90)
Affinity DataKd:  9.50E+3nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661329(US20240101552, Compound L-89)
Affinity DataKd:  2.53E+3nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661340(US20240101552, Compound L-102)
Affinity DataKd:  2.95E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661327(US20240101552, Compound L-83)
Affinity DataKd:  5.37E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661326(US20240101552, Compound L-82)
Affinity DataKd:  4.23E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661325(US20240101552, Compound L-81)
Affinity DataKd:  2.30E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661324(US20240101552, Compound L-80)
Affinity DataKd:  2.84E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661323(US20240101552, Compound L-79)
Affinity DataKd:  2.48E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661322(US20240101552, Compound L-78)
Affinity DataKd:  8.15E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661321(US20240101552, Compound L-77)
Affinity DataKd:  1.90E+3nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661320(US20240101552, Compound L-74)
Affinity DataKd:  2.58E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661319(US20240101552, Compound L-73)
Affinity DataKd:  8.73E+3nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661318(US20240101552, Compound L-72)
Affinity DataKd:  6.93E+3nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661317(US20240101552, Compound L-71)
Affinity DataKd:  4.06E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661352(US20240101552, Compound L-117)
Affinity DataKd:  2.70E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM50558735(CHEMBL4788758 | US20240101552, Compound BT-11)
Affinity DataKd:  7.70E+3nMAssay Description:Binding affinity to LANCL2 (unknown origin) by surface plasmon resonance analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details Article
PubMed
TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661362(US20240101552, Compound L-127)
Affinity DataKd:  9.38E+3nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661361(US20240101552, Compound L-126)
Affinity DataKd:  4.05E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661360(US20240101552, Compound L-125)
Affinity DataKd:  2.35E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661359(US20240101552, Compound L-124)
Affinity DataKd:  8.79E+3nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661358(US20240101552, Compound L-123)
Affinity DataKd:  1.83E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661357(US20240101552, Compound L-122)
Affinity DataKd:  1.03E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661356(US20240101552, Compound L-121)
Affinity DataKd:  2.08E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661355(US20240101552, Compound L-120)
Affinity DataKd:  2.21E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661354(US20240101552, Compound L-119)
Affinity DataKd:  6.78E+3nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661353(US20240101552, Compound L-118)
Affinity DataKd:  8.73E+3nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661269(US20240101552, Compound L-1)
Affinity DataKd:  4.46E+3nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661351(US20240101552, Compound L-116)
Affinity DataKd:  1.48E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661350(US20240101552, Compound L-115)
Affinity DataKd:  1.77E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661349(US20240101552, Compound L-114)
Affinity DataKd:  1.08E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661348(US20240101552, Compound L-112)
Affinity DataKd:  2.48E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661347(US20240101552, Compound L-110)
Affinity DataKd:  2.62E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661346(US20240101552, Compound L-108)
Affinity DataKd:  4.84E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661345(US20240101552, Compound L-107)
Affinity DataKd:  6.19E+3nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661344(US20240101552, Compound L-106)
Affinity DataKd:  4.32E+3nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661343(US20240101552, Compound L-105)
Affinity DataKd:  1.75E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661342(US20240101552, Compound L-104)
Affinity DataKd:  1.25E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661341(US20240101552, Compound L-103)
Affinity DataKd:  2.41E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661280(US20240101552, Compound L-16)
Affinity DataKd:  8.49E+4nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

TargetLanC-like protein 2(Human)
Shanghai Pharmaceuticals Holding Co.

US Patent
LigandPNGBDBM661291(US20240101552, Compound L-38)
Affinity DataKd:  9.09E+3nMAssay Description:1. Experimental Materials1.1 Reagent MaterialsLigand: LANCL2Running buffer: 20 mM MES, 150 mM NaCl, 0.05% P20, pH 6.5, 1% DMSO1.2 EquipmentsEquipment...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
US Patent

Displayed 1 to 50 (of 97 total ) | Next | Last >>
Jump to: